Skip to main content

From conversation to source of truth.

Watch what the peptide world is saying, then see what the published evidence actually supports. Community experience stays clearly separate from research.

Watch

See what's happening.

The freshest relevance-ranked video intelligence from the peptide world — real creators, summarised and cross-linked to the compounds they discuss. Playback stays inside PEPTD.

  • Tirzepatide

Tirzepatide Does More Than Suppress Appetite — Heart, Liver, Sleep

ThinWorksOct 27, 2026

Why it matters · PEPTD AI summary

In this educational video, representatives from ThinWorks discuss potential physiological effects of tirzepatide beyond appetite suppression. The presentation focuses on how the dual GIP/GLP-1 receptor agonist may influence cardiovascular parameters like blood pressure, fatty liver disease, systemic inflammation, and obstructive sleep apnea.

Creator commentaryYouTube · plays inside PEPTD
Watch
  • Retatrutide
  • Semaglutide

Age Reversal Properties of Retatrutide, Tirzepatide & Semaglutide Explained

Doctor Michael MuellerOct 27, 2026

Why it matters · PEPTD AI summary

The creator reviews published literature exploring how incretin mimetics, including retatrutide, tirzepatide, and semaglutide, influence mitochondrial function and cellular health. The discussion highlights research regarding hepatic mitochondrial dynamics, skeletal muscle energy efficiency, and glucagon-mediated lipid beta-oxidation as potential mechanisms linked to metabolic and cellular longevity.

Physician commentaryYouTube · plays inside PEPTD
Watch

Learn

Understand what the evidence says.

One subject at a time, translated into a graded intelligence card: what the research supports, what is still open, and where the sources are.

Learn intelligence card · Healing

BPC-157

Clinical Trial Only

Takeaway

Studied in animal models for tissue repair. Human evidence is limited.

  • Peer-reviewed research3 studies
  • Clinical registry2 trials
  • Creator commentary517 video briefings

What we know

  • Reported in preclinical studies to influence angiogenesis, growth factor expression, and nitric oxide pathways involved in tissue repair.

What remains uncertain

  • Long-term human safety, optimal route of administration, and effective dose ranges are not established.

Known risks · Not approved for human use by FDA. Human safety data is limited.

Key indexed sources

  • Registered trialBPC 157 for Acute Hamstring Muscle Strain Repair
  • Registered trialA Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery
  • Peer-reviewedEffects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.

Reviewed Jun 13, 2026Educational summary · not medical advice

Industry Pulse

Questions moving through the peptide world.

Recurring public questions and concerns, paraphrased and routed to the video, research or tool that actually helps.

From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.

Common questionReconstitution & dosing math

How do I know whether my reconstitution math is actually right?

Reconstitution math is one of the most persistent sources of confusion in public peptide discussions — people repeatedly ask others to sanity-check mg, mL and syringe-unit conversions before drawing anything.

ReconstitutionSyringe unitsBeginner

From public discussions · Summarised from public peptide discussions. Not posted by PEPTD members, and not medical evidence.

Captured from r/Peptidesource

Watch · Learn · Build

Then make it yours.

Save what matters, follow the subjects you care about, build your own stack, and share it with a link that leads straight back to the source.

Join PEPTD — it's free to start